Kezar Life Sciences, Inc. — Director's Dealing 2021

Sep 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2021-09-21

Reporting Person: BERGER FRANKLIN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-21	Common Stock	M	8896	$5.91	Acquired	792899	Direct
2021-09-21	Common Stock	M	8896	$7.63	Acquired	801795	Direct
2021-09-22	Common Stock	M	8896	$5.60	Acquired	810691	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-21	Stock Option (Right to Buy)	$5.91	M	8896	Disposed	2028-04-16	Common Stock (8896)	Direct
2021-09-21	Stock Option (Right to Buy)	$7.63	M	8896	Disposed	2029-06-25	Common Stock (8896)	Direct
2021-09-22	Stock Option (Right to Buy)	$5.60	M	8896	Disposed	2030-06-24	Common Stock (8896)	Direct

Footnotes

F1: One-hundred percent (100%) of the shares subject to the option vested on 1/1/2019.

F2: One-hundred percent (100%) of the shares subject to the option vested on 6/25/2020.

F3: One-hundred percent (100%) of the shares subject to the option vested on 6/24/2021.